In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

The World Health Organization continues its investigation into the origins of COVID-19, with significant information still ...